Level C· Early human research exploring benefitsProspective StudyEurope PMC

Adipocyte hypertrophy-hyperplasia balance contributes to weight loss after bariatric surgery

Muir LA., Baker NA., Washabaugh AR., Neeley CK., Flesher CG., DelProposto JB.

Prospective Study on Type 2 Diabetes, published in Adipocyte (2017) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Prospective Study
Journal
Adipocyte (2017)
Reported sample size
—
Source database
Europe PMC
PMID
28425841
PMCID
PMC5477697
DOI
10.1080/21623945.2017.1287639
Citations
22

Abstract (original English)

Predictors of weight loss responses are not well-defined. We hypothesized that adipose tissue phenotypic features related to remodeling would be associated with bariatric surgery weight loss responses. Visceral and subcutaneous adipose tissues collected from patients during bariatric surgery were studied with flow cytometry, immunohistochemistry, and QRTPCR, and results correlated with weight loss outcomes. Age, male sex, and a diagnosis of type 2 diabetes were associated with less weight loss. Adipocyte size was increased and preadipocyte frequency was decreased in visceral adipose tissue from diabetic subjects. Decreased adipose tissue preadipocyte frequency was associated with less weight loss in women but not men. These data suggest that phenotypic features of adipose tissue remodeling may predict responses to weight loss interventions.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence
Adipose TissueAdipocytesHumansObesityHypertrophyHyperplasiaWeight LossTreatment OutcomeFemaleMale

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research